137 related articles for article (PubMed ID: 38176673)
21. Advancements of Prussian blue-based nanoplatforms in biomedical fields: Progress and perspectives.
Wang Y; Liang Z; Liang Z; Lv W; Chen M; Zhao Y
J Control Release; 2022 Nov; 351():752-778. PubMed ID: 36216173
[TBL] [Abstract][Full Text] [Related]
22. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
[TBL] [Abstract][Full Text] [Related]
23. Controllable synthesis of rare earth (Gd
Xu M; Chi B; Han Z; He Y; Tian F; Xu Z; Li L; Wang J
Dalton Trans; 2020 Sep; 49(35):12327-12337. PubMed ID: 32844843
[TBL] [Abstract][Full Text] [Related]
24. Biofunctionalized prussian blue nanoparticles for multimodal molecular imaging applications.
Vojtech JM; Cano-Mejia J; Dumont MF; Sze RW; Fernandes R
J Vis Exp; 2015 Apr; (98):e52621. PubMed ID: 25993028
[TBL] [Abstract][Full Text] [Related]
25. Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
Fétiveau L; Paul G; Nicolas-Boluda A; Volatron J; George R; Laurent S; Muller R; Sancey L; Mejanelle P; Gloter A; Gazeau F; Catala L
Chem Commun (Camb); 2019 Dec; 55(98):14844-14847. PubMed ID: 31768507
[TBL] [Abstract][Full Text] [Related]
26. Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications.
Busquets MA; Estelrich J
Drug Discov Today; 2020 Aug; 25(8):1431-1443. PubMed ID: 32492486
[TBL] [Abstract][Full Text] [Related]
27. Magnetic Prussian blue nanoparticles for targeted photothermal therapy under magnetic resonance imaging guidance.
Fu G; Liu W; Li Y; Jin Y; Jiang L; Liang X; Feng S; Dai Z
Bioconjug Chem; 2014 Sep; 25(9):1655-63. PubMed ID: 25109612
[TBL] [Abstract][Full Text] [Related]
28. A nanohybrid of Prussian blue supported by boracic acid-modified g-C
Wang YN; Zhang WS; Liu XP; Wei YY; Xu ZR
Colloids Surf B Biointerfaces; 2022 Jul; 215():112490. PubMed ID: 35405536
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional Biodegradable Prussian Blue Analogue for Synergetic Photothermal/Photodynamic/Chemodynamic Therapy and Intrinsic Tumor Metastasis Inhibition.
Hao Y; Mao L; Zhang R; Liao X; Yuan M; Liao W
ACS Appl Bio Mater; 2021 Sep; 4(9):7081-7093. PubMed ID: 35006940
[TBL] [Abstract][Full Text] [Related]
30. Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy.
Hong H; Kim M; Lee W; Jeon M; Lee C; Kim H; Im HJ; Piao Y
J Nanobiotechnology; 2023 Oct; 21(1):365. PubMed ID: 37798714
[TBL] [Abstract][Full Text] [Related]
31. A novel theranostic nano-platform (PB@FePt-HA-g-PEG) for tumor chemodynamic-photothermal co-therapy and triple-modal imaging (MR/CT/PI) diagnosis.
Hu Z; Wang S; Dai Z; Zhang H; Zheng X
J Mater Chem B; 2020 Jun; 8(24):5351-5360. PubMed ID: 32458958
[TBL] [Abstract][Full Text] [Related]
32. Monodispersed plasmonic Prussian blue nanoparticles for zero-background SERS/MRI-guided phototherapy.
Zhu W; Gao MY; Zhu Q; Chi B; Zeng LW; Hu JM; Shen AG
Nanoscale; 2020 Feb; 12(5):3292-3301. PubMed ID: 31971195
[TBL] [Abstract][Full Text] [Related]
33. Progress in the preparation of Prussian blue-based nanomaterials for biomedical applications.
Lu K; Zhu XY; Li Y; Gu N
J Mater Chem B; 2023 Jun; 11(24):5272-5300. PubMed ID: 36748242
[TBL] [Abstract][Full Text] [Related]
34. Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and Metabolomics.
Qu H; Jin X; Cheng W; Wu D; Ma B; Lou C; Zheng J; Jing L; Xue X; Wang Y
Part Fibre Toxicol; 2023 May; 20(1):18. PubMed ID: 37147710
[TBL] [Abstract][Full Text] [Related]
35. Polydopamine-containing nano-systems for cancer multi-mode diagnoses and therapies: A review.
Li M; Xuan Y; Zhang W; Zhang S; An J
Int J Biol Macromol; 2023 Aug; 247():125826. PubMed ID: 37455006
[TBL] [Abstract][Full Text] [Related]
36. Synergistic Therapy Using Doxorubicin-Loading and Nitric Oxide-Generating Hollow Prussian Blue Nanoparticles with Photoacoustic Imaging Potential Against Breast Cancer.
Fu J; Wu Q; Dang Y; Lei X; Feng G; Chen M; Yu XY
Int J Nanomedicine; 2021; 16():6003-6016. PubMed ID: 34511902
[TBL] [Abstract][Full Text] [Related]
37. Tumor-Microenvironment-Triggered Ion Exchange of a Metal-Organic Framework Hybrid for Multimodal Imaging and Synergistic Therapy of Tumors.
Chen Y; Li ZH; Pan P; Hu JJ; Cheng SX; Zhang XZ
Adv Mater; 2020 Jun; 32(24):e2001452. PubMed ID: 32374492
[TBL] [Abstract][Full Text] [Related]
38. Bufotalin-loaded biomimetic Prussian blue nanoparticles for colorectal cancer chemo-photothermal ferroptosis therapy.
Wu Y; Tian J; Yang J; Peng Q; Wu Z; Liu R; Luo M; Qiu Y; Cao R
Nanomedicine (Lond); 2024 Jan; 19(2):109-125. PubMed ID: 38197393
[No Abstract] [Full Text] [Related]
39. Silver Prussian Blue Analogue Nanoparticles: Rationally Designed Advanced Nanomedicine for Multifunctional Biomedical Applications.
Mukherjee S; Kotcherlakota R; Haque S; Das S; Nuthi S; Bhattacharya D; Madhusudana K; Chakravarty S; Sistla R; Patra CR
ACS Biomater Sci Eng; 2020 Jan; 6(1):690-704. PubMed ID: 33463227
[TBL] [Abstract][Full Text] [Related]
40. Size-Controllable Prussian Blue Nanoparticles Using Pluronic Series for Improved Antioxidant Activity and Anti-Inflammatory Efficacy.
Oh H; Lee JS; Sung D; Yang S; Choi WI
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
